NEW YORK (GenomeWeb) – CombiMatrix said today that it has entered into a contractual agreement with Fortified Provider Network for coverage of CombiMatrix's suite of diagnostic laboratory services.

FPN has more than 200 payor clients nationwide and contracts with physicians, hospitals, ancillary facilities, mid-level providers, and other specialty healthcare providers who have the option of participating in one or more of its products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.